Intellectual Property Law and Access to Medicines

TRIPS Agreement, Health, and Pharmaceuticals
Herausgeber: Ragavan, Srividhya; Vanni, Amaka

• Gebundenes Buch

Produktbeschreibung

This book details the historical trajectory of the global struggle to access medicines.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 504
• Erscheinungstermin: 29. Juli 2021
• Englisch
• Abmessung: 234mm x 156mm x 29mm
• Gewicht: 903g
• ISBN-13: 9780367436384
• ISBN-10: 0367436388
• Artikelnr.: 69937957

Autorenporträt

Srividhya Ragavan is a Professor of Law and Director of the India Program at Texas A&M University School of Law, Texas, United States. Amaka Vanni is an Assistant Professor at School of Law, University of Leeds, United Kingdom.

Inhaltsangabe

Introduction Access to Medicine and TRIPS Agreement: A Historiographic
Mapping of the Tradescape Srividhya Ragavan and Amaka Vanni Part I:
International Norm Setting and Patent Metamorphosis: First Generation 1.
World Trade Organization: A Barrier to Global Public Health? Srividhya
Ragavan 2. World Health Organization: Contributions to Access to Health and
TRIPS Agreement Discourse Susan Isiko trba 3. From TRIPS to Access to
Medicines: What's There in Between? Sergio Napolitano 4. Free Trade
Agreements: Longer, Further, Deeper Impact on Pharmaceutical Patents Bryan
Mercurio 5. From the TPP to USMCA: A High-Powered Battle over Biologics
Burcu Kilic 6. African Union Continental Free Trade Area: Opportunities for
New Regional Discourse? J. Janewa Osei-Tutu 7. U.S. Litigated Government
Funded Patents in Europe and Japan: A First Look Teo Firpo and Michael S.
Mireles Part II: State Action and the Access to Medicine Debate: Second
Generation 8. Brazil: Patent Barriers and Access to Medicine through Public
Health System Gabriela Costa Chaves, Maria Auxiladora Oliveira, and Jorge
Antonio Zepeda Bermudez 9. China: From Struggle to Surge: China's TRIPS
Experience and its Lessons for Access to Medicines Peter K. Yu 10. Canada:
Access to Medicine in High-Income Countries Gaëlle Groux and Jeremy de Beer
11. India: Pharmaceutical Patents and Evergreen Battle for Access to
Medicine Anand Grover 12. South Africa's Three Decades of Access to
Medicine Discourse: Blight or Benefit Caroline B. Ncube 13. Thailand:
Shooting Star for Access to Medicine through Compulsory Licensing Van Anh
Le 14. United States: Unilateral Norm Setting Using Special 301 Michael
Palmedo Part III: Global Patterns and Emerging Issues: Third Generation
15. Access to Medicines Activism: Collaboration, Conflicts, and
Complementarities Brook K. Baker 16. GTPI: Experiences to Overcome IP
Barriers to Increase Access to Medicine Felipe de Carvalho Borges da
Fonseca, Marcela Fogaça Vieira, and Pedro Villardi 17. Private Sector:
Right to Health Responsibilities of Pharmaceutical Companies Emmanuel
Kolawole Oke 18. Competition: Can Excessive Pricing be Fixed through Abuse
of Dominant Position? Shirin Syed 19. The Unique World of Pharmaceutical
Intellectual Property Rights Emily Michiko Morris 20. Innovation Policies:
Roadblocks to Establishing Sustainable Pharmaceutical Innovation Policies
Doris Estelle Long 21. Not Just Patents and Data Exclusivity: The Role of
Trademarks in Integrated IP Strategy - Where Lies the Public Interest?
Graham Dutfield 22. Indigenous Knowledge: Bridging with Modern Medicine
Anthony C. K. Kakooza 23. Digital Divide and Access to Medicine: The Debate
Swaraj Paul Barooah Part IV: COVID-19 and Access to Medicines Lessons from
COVID-19 for Medicine Access Amaka Vanni